Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial

BACKGROUND: To investigate whether saxagliptin add-on therapy to continuous subcutaneous insulin infusion (CSII) further improve blood glycemic control than CSII therapy in patients with newly diagnosed type 2 diabetes (T2D). METHODS: This was a single-center, randomized, control, open-labeled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng-fei, Jiang, Lan-lan, Yan, Reng-na, Zhu, Hong-hong, Zhou, Pei-hua, Zhang, Dan-feng, Su, Xiao-fei, Wu, Jin-dan, Ye, Lei, Ma, Jian-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089116/
https://www.ncbi.nlm.nih.gov/pubmed/27787387
http://dx.doi.org/10.1097/MD.0000000000005229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089116/
https://www.ncbi.nlm.nih.gov/pubmed/27787387
http://dx.doi.org/10.1097/MD.0000000000005229

Ejemplares similares